moclobemide has been researched along with Agoraphobia in 5 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Agoraphobia: Obsessive, persistent, intense fear of open places.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This case report deals with a patient with a long history of panic disturbances including agoraphobia, social phobia, depressive moods and alcohol abuse, whose condition remitted only after applying a supplementary treatment, using Imipramine and Moclobimide in conjunction with behavioural therapy." | 7.69 | [Treatment refractory panic disorder--success of a combined treatment with imipramine, moclobemide and behavior therapy]. ( Boerner, RJ, 1995) |
| "In the treatment of panic disorder with agoraphobia, the efficacy of pharmacological, psychological and combined treatments has been established." | 6.69 | Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia. ( Benkert, O; Graf-Morgenstern, M; Hain, C; Hautzinger, M; Loerch, B; Sandmann, J; Schlegel, S, 1999) |
| " This case report deals with a patient with a long history of panic disturbances including agoraphobia, social phobia, depressive moods and alcohol abuse, whose condition remitted only after applying a supplementary treatment, using Imipramine and Moclobimide in conjunction with behavioural therapy." | 3.69 | [Treatment refractory panic disorder--success of a combined treatment with imipramine, moclobemide and behavior therapy]. ( Boerner, RJ, 1995) |
| "In the treatment of panic disorder with agoraphobia, the efficacy of pharmacological, psychological and combined treatments has been established." | 2.69 | Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia. ( Benkert, O; Graf-Morgenstern, M; Hain, C; Hautzinger, M; Loerch, B; Sandmann, J; Schlegel, S, 1999) |
| "Moclobemide was effective in both major components of social phobia (fear and avoidance)." | 2.67 | Moclobemide in social phobia: a pilot open study. GRP Group. Groupe de Recherche en Psychopharmacologie. ( Bisserbe, JC; Lépine, JP, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Warwick, JM | 1 |
| Carey, P | 1 |
| Van der Linden, G | 1 |
| Prinsloo, C | 1 |
| Niehaus, D | 1 |
| Seedat, S | 1 |
| Dupont, P | 1 |
| Stein, DJ | 1 |
| Boerner, RJ | 1 |
| Bisserbe, JC | 1 |
| Lépine, JP | 1 |
| Loerch, B | 1 |
| Graf-Morgenstern, M | 1 |
| Hautzinger, M | 1 |
| Schlegel, S | 1 |
| Hain, C | 1 |
| Sandmann, J | 1 |
| Benkert, O | 1 |
| Bakish, D | 1 |
2 trials available for moclobemide and Agoraphobia
| Article | Year |
|---|---|
Moclobemide in social phobia: a pilot open study. GRP Group. Groupe de Recherche en Psychopharmacologie.
Topics: Adult; Agoraphobia; Benzamides; Female; Humans; Male; Middle Aged; Moclobemide; Monoamine Oxidase In | 1994 |
Randomised placebo-controlled trial of moclobemide, cognitive-behavioural therapy and their combination in panic disorder with agoraphobia.
Topics: Adolescent; Adult; Aged; Agoraphobia; Analysis of Variance; Antidepressive Agents; Benzamides; Cogni | 1999 |
3 other studies available for moclobemide and Agoraphobia
| Article | Year |
|---|---|
A comparison of the effects of citalopram and moclobemide on resting brain perfusion in social anxiety disorder.
Topics: Adult; Agoraphobia; Antidepressive Agents; Brain; Cerebrovascular Circulation; Citalopram; Female; H | 2006 |
[Treatment refractory panic disorder--success of a combined treatment with imipramine, moclobemide and behavior therapy].
Topics: Adult; Agoraphobia; Antidepressive Agents; Behavior Therapy; Benzamides; Combined Modality Therapy; | 1995 |
Reversible monoamine-A inhibitors in panic disorder.
Topics: Agoraphobia; Benzamides; Humans; Moclobemide; Monoamine Oxidase Inhibitors; Panic Disorder; Psychiat | 1992 |